Article
CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
Gene - 10 Jan 2013
Bayram Süleyman, Akkız Hikmet, Topaktaş Mehmet
Abstract excerpt
AIM: The cell cycle checkpoint kinase 2 (CHK2) protein participates in the DNA damage response in many cell types. Germline mutations in CHK2 (1100delC, IVS2+1G>A and I157T) have been associated with a range of cancer types. This study aimed to investigate whether CHK2 1100delC, IVS2+1G>A and I15...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
